Nektar Therapeutics (NKTR)
1.38
-0.04
(-2.82%)
USD |
NASDAQ |
Apr 24, 16:00
1.39
+0.01
(+0.72%)
After-Hours: 20:00
Nektar Therapeutics Total Liabilities (Quarterly): 267.05M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 267.05M |
| September 30, 2023 | 282.88M |
| June 30, 2023 | 297.32M |
| March 31, 2023 | 320.88M |
| December 31, 2022 | 343.96M |
| September 30, 2022 | 368.78M |
| June 30, 2022 | 403.26M |
| March 31, 2022 | 416.23M |
| December 31, 2021 | 437.68M |
| September 30, 2021 | 475.70M |
| June 30, 2021 | 466.38M |
| March 31, 2021 | 462.06M |
| December 31, 2020 | 461.47M |
| September 30, 2020 | 337.68M |
| June 30, 2020 | 338.64M |
| March 31, 2020 | 591.51M |
| December 31, 2019 | 571.96M |
| September 30, 2019 | 599.58M |
| June 30, 2019 | 542.50M |
| March 31, 2019 | 532.97M |
| December 31, 2018 | 432.60M |
| September 30, 2018 | 458.98M |
| June 30, 2018 | 452.67M |
| March 31, 2018 | 438.51M |
| December 31, 2017 | 421.04M |
| Date | Value |
|---|---|
| September 30, 2017 | 497.89M |
| June 30, 2017 | 472.47M |
| March 31, 2017 | 483.74M |
| December 31, 2016 | 480.75M |
| September 30, 2016 | 492.95M |
| June 30, 2016 | 502.35M |
| March 31, 2016 | 492.15M |
| December 31, 2015 | 492.21M |
| September 30, 2015 | 410.19M |
| June 30, 2015 | 421.57M |
| March 31, 2015 | 421.91M |
| December 31, 2014 | 405.29M |
| September 30, 2014 | 429.68M |
| June 30, 2014 | 513.50M |
| March 31, 2014 | 496.82M |
| December 31, 2013 | 524.43M |
| September 30, 2013 | 433.28M |
| June 30, 2013 | 453.36M |
| March 31, 2013 | 450.52M |
| December 31, 2012 | 450.77M |
| September 30, 2012 | 446.12M |
| June 30, 2012 | 536.16M |
| March 31, 2012 | 532.30M |
| December 31, 2011 | 408.74M |
| September 30, 2011 | 417.30M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
267.05M
Minimum
Dec 2023
599.58M
Maximum
Sep 2019
420.29M
Average
416.23M
Median
Mar 2022
Total Liabilities (Quarterly) Benchmarks
| Stereotaxis Inc | 19.99M |
| Vanda Pharmaceuticals Inc | 103.53M |
| Cara Therapeutics Inc | 68.76M |
| Marinus Pharmaceuticals Inc | 154.14M |
| DiaMedica Therapeutics Inc | 3.103M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 398.03M |
| Shareholders Equity (Quarterly) | 130.99M |
| Current Ratio | 6.450 |